(Q44206306)

30 November 2017

Naloxone antagonizes behavioural effects of d-amphetamine in mice and rats (English)

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

19 July 2023

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

19 July 2023

author name string

P. W. Dettmar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A570648

19 July 2023

A. Cowan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A570648

19 July 2023

D. S. Walter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A570648

19 July 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=570648

19 July 2023

publication date

1 December 1978

1 reference

full work available at URL

30 November 2017

https://api.elsevier.com/content/article/PII:002839087890031X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

https://api.elsevier.com/content/article/PII:002839087890031X?httpAccept=text/plain

19 July 2023

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

19 July 2023

1 reference

30 November 2017

17

1 reference

30 November 2017

12

1 reference

30 November 2017

1041-1044

1 reference

Nitrous oxide analgesia: reversal by naloxone and development of tolerance

30 November 2017

1

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

The effects of naloxone and picrotoxin on the sedative and anticonflict effects of benzodiazepines

19 July 2023

2

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Endorphins: Profound Behavioral Effects in Rats Suggest New Etiological Factors in Mental Illness

19 July 2023

3

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Naloxone-induced inhibition of ethanol dependence in mice

19 July 2023

4

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Effects of amphetamine on the turnover rate of brain catecholamines and motor activity

19 July 2023

6

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats

19 July 2023

10

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Intravenous Naloxone Administration in Schizophrenia and Affective Illness

19 July 2023

11

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

New Tables for Multiple Comparisons with a Control

19 July 2023

12

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Indication of an Antipsychotic Action of the Opiate Antagonist Naloxone

19 July 2023

13

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugs

19 July 2023

14

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

The influence of naloxone on barbiturate anesthesia and toxicity in the rat.

19 July 2023

15

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Naloxone-induced reversal of schizophrenic hallucinations

19 July 2023

17

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Behavioral interactions between naloxone and dopamine agonists

19 July 2023

18

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Behavioral effects of separate and combined administration of naloxone and d-amphetamine

19 July 2023

20

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Effects of narcotic antagonists on fluid intake in the rat

19 July 2023

21

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat

19 July 2023

22

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Lack of effect on naloxone on schizophrenic symptoms

19 July 2023

23

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride

19 July 2023

25

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice.

19 July 2023

26

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Interactions between naloxone and chlorpromazine on behavior under schedule control

19 July 2023

27

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Effects of narcotic analgesics upon the locomotor activity and brain catecholamine content of the mouse

19 July 2023

29

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

The effects of acutely administered analgesics on the turnover of noradrenaline and dopamine in various regions of the rat brain

19 July 2023

30

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

19 July 2023

32

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

Naloxone in chronic schizophrenia

19 July 2023

33

1 reference

https://api.crossref.org/works/10.1016/0028-3908(78)90031-X

19 July 2023

Identifiers

1 reference

30 November 2017

1 reference